Menu
Back to User profile » Dr Alan Kaplan
Papers published by Dr Alan Kaplan:
Variation in Demographic and Clinical Characteristics of Patients with COPD Receiving Care in US Primary Care: Data from the Advancing the Patient EXperience (APEX) in COPD Registry
Fox C, Pace W, Brandt E, Carter V, Chang KL, Edwards C, Evans A, Gaona G, Han MK, Kaplan A, Kent R, Kocks JWH, Kruszyk M, Le Lievre Chantal, LiVoti TM, Mahle C, Make B, Ratigan A, Shaikh A, Skolnik N, Stanley B, Yawn BP, Price DB
Pragmatic and Observational Research 2022, 13:17-31
Published Date: 29 April 2022
GOLD 2021 Strategy Report: Implications for Asthma–COPD Overlap
Roman-Rodriguez M, Kaplan A
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1709-1715
Published Date: 14 June 2021
Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes
Price D, Jones R, Pfister P, Cao H, Carter V, Kemppinen A, Holzhauer B, Kaplan A, Clark A, Halpin DMG, Pinnock H, Chalmers JD, van Boven JF, Beeh KM, Kostikas K, Roche N, Usmani OA, Mastoridis P
Pragmatic and Observational Research 2021, 12:25-35
Published Date: 24 May 2021
Treatment Adherence in Adolescents with Asthma
Kaplan A, Price D
Journal of Asthma and Allergy 2020, 13:39-49
Published Date: 14 January 2020
Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study
Kaplan A, Chapman KR, Anees SM, Mayers I, Rochdi D, Djandji M, Préfontaine D, McIvor A
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:249-260
Published Date: 18 January 2019
Matched cohort study of therapeutic strategies to prevent preschool wheezing/asthma attacks
Grigg J, Nibber A, Paton JY, Chisholm A, Guilbert TW, Kaplan A, Turner S, Roche N, Hillyer EV, Price DB
Journal of Asthma and Allergy 2018, 11:309-321
Published Date: 11 December 2018
Are blood eosinophils a prime-time biomarker for COPD management decisions?
Tsiligianni I, Kaplan AG
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1889-1891
Published Date: 12 June 2018
Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study
Dollerup J, Vestbo J, Murray-Thomas T, Kaplan A, Martin RJ, Pizzichini E, Pizzichini MMM, Burden A, Martin J, Price DB
Clinical Epidemiology 2017, 9:231-243
Published Date: 26 April 2017
Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice
Kaplan AG
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2535-2548
Published Date: 20 November 2015
Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide
Price D, Kaplan A, Jones R, Freeman D, Burden A, Gould S, von Ziegenweidt J, Ali M, King C, Thomas M
Journal of Asthma and Allergy 2015, 8:1-13
Published Date: 14 January 2015
Assessment of COPD wellness tools for use in primary care: an IPCRG initiative
Cave AJ, Atkinson L, Tsiligianni IG, Kaplan AG
International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:447-456
Published Date: 17 July 2012